Advertisement

Drugs & Therapy Perspectives

, Volume 8, Issue 4, pp 1–5 | Cite as

Pantoprazole is a highly effective option for gastric acid-related disorders

New Drugs and Therapeutic
  • 4 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fitton A, Wiseman L. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 1996 Mar; 51(3): 460–82Google Scholar
  2. 2.
    Spencer CM, Faulds D. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders. Drugs 1994; 48(3): 404–430Google Scholar
  3. 3.
    Wilde MI, McTavish D. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders. Drugs 1994; 48(1): 91–132Google Scholar
  4. 4.
    Pantoprazole launched in France. Scrip 1996 Apr 2; (2116): 19Google Scholar
  5. 5.
    Benet LZ, Zech K. Pharmacokinetics — a relevant factor for the choice of a drug? Aliment Pharmacol Ther 1994; 8 (Suppl.l): 25–32PubMedGoogle Scholar
  6. 6.
    British National Formulary No. 31. London: The Pharmaceutical Press, 1996 Mar: 37–40, 556Google Scholar
  7. 7.
    Kromer W. Similarities and differences in the properties of substituted benzimidazoles: a comparison between pantoprazole and related compounds. Digestion 1995; 56: 443–454PubMedCrossRefGoogle Scholar
  8. 8.
    Hotz J, Plein K, Schönekäs H. Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer. Scand J Gastroenterol 1995 Feb;30: 111–5PubMedCrossRefGoogle Scholar
  9. 9.
    Witzel L, Gütz H, Hüttermann W, et al. Pantoprazole versus omeprazole in the treatment of acute gastric ulcers. Aliment Pharmacol Ther 1995 Feb; 9: 19–24PubMedCrossRefGoogle Scholar
  10. 10.
    Hahn EG, Dammann HG, Adler G, et al. Pantoprazole provides faster healing and pain relief than famotidine in acute duodenal ulcer disease. Gastroenterology. In press.Google Scholar
  11. 11.
    Koop H, Schepp W, Dammann HG, et al. Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis: results of a German multicenter study. J Clin Gastroenterol 1995 Apr; 20: 192–5PubMedCrossRefGoogle Scholar
  12. 12.
    Dammann HG, Hahn EG, Adler G, et al. Pantoprazole is more effective than famotidine in acute gastro-esophageal reflux disease. Gastroenterology. In press.Google Scholar
  13. 13.
    Brunner G, Harke U. Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. Aliment Pharmacol Ther 1994; 8 Suppl. 1: 59–64PubMedGoogle Scholar
  14. 14.
    Bardhan KD, Cherian P, Polak JM, et al. Pantoprazole (PANTO) in aggressive or refractory acid-peptic disease. Gastroenterology. In press.Google Scholar
  15. 15.
    Suerbaum S, Leying H, Klemm K, et al. Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1991 Feb; 10: 92–3PubMedCrossRefGoogle Scholar
  16. 16.
    Scholten T, Adler G, Bosseckert H, et al. Clinical tolerability of pantoprazole compared to H2-antagonists: results of the German pantoprazole phase IV program. Gastroenterology. In pressGoogle Scholar

Copyright information

© Adis International Limited 1996

Personalised recommendations